Medicamen Organics (NSE:MEDIORG) Inventories, Work In Process: ₹0.00 Mil (As of Mar. 2026)


NSE:MEDIORG Medicamen Organics Ltd NSE:MEDIORG
32 GF Score
Price ₹23.80
! 11 Warning Signs
View Full Analysis

What is Medicamen Organics Inventories, Work In Process?

Medicamen Organics NSE:MEDIORG -4.99% 32 Inventories, Work In Process is ₹0.00 Mil as of Mar. 2026. GuruFocus rates NSE:MEDIORG with a GF Score™ of 32/100. The stock has 11 warning signs investors should review.

Work in process is the part of a manufacturer's inventory that is in the production process and has not yet been completed and transferred to the finished goods inventory. Medicamen Organics's work in process for the quarter that ended in Mar. 2026 was ₹0.00 Mil.

Medicamen Organics Inventories, Work In Process Historical Data

* Premium members only.

The historical data trend for Medicamen Organics's Inventories, Work In Process can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medicamen Organics Inventories, Work In Process Chart

Medicamen Organics Annual Data
Trend Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Inventories, Work In Process
Get a 7-Day Free Trial 6.61 15.06 17.80 18.37 0.00

Medicamen Organics Semi-Annual Data
Mar21 Mar22 Mar23 Sep23 Mar24 Mar25 Mar26
Inventories, Work In Process Get a 7-Day Free Trial 15.06 11.90 17.80 18.37 0.00
NSE:MEDIORG
32GF Score
Medicamen Organics Ltd NSE:MEDIORG
Inventories, Work In Process is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Medicamen Organics Inventories, Work In Process Calculation

That part of a manufacturer's inventory that is in the production process and has not yet been completed and transferred to the finished goods inventory. This account contains the cost of the direct material, direct labor, and factory overhead placed into the products on the factory floor. A manufacturer must disclose in its financial statements the cost of its work-in-process as well as the cost of finished goods and materials on hand.

What does a Inventories, Work In Process of ₹0.00 Mil mean?
Medicamen Organics (NSE:MEDIORG) has a Inventories, Work In Process of ₹0.00 Mil as of Mar. 2026. Work in progress is the portion of inventory containing goods that are unfinished. View historical data on Medicamen Organics and its competitors.
Is Medicamen Organics' Inventories, Work In Process too high?
Medicamen Organics' current Inventories, Work In Process is ₹0.00 Mil. Overall, Medicamen Organics has a GF Score™ of 32/100, reflecting its overall financial health beyond just this single metric.
How does Medicamen Organics' Inventories, Work In Process compare to ZTS and UTHR?
Medicamen Organics' Inventories, Work In Process of ₹0.00 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Inventories, Work In Process for a Drug Manufacturers company?
A good Inventories, Work In Process depends on the Drug Manufacturers industry context. However, Inventories, Work In Process should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Inventories, Work In Process mean?
A high Inventories, Work In Process can signal that a stock is expensive relative to its fundamentals. Work in progress is the portion of inventory containing goods that are unfinished. View historical data on Medicamen Organics and its competitors. Medicamen Organics's current Inventories, Work In Process is ₹0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medicamen Organics stock overvalued right now?
Medicamen Organics (NSE:MEDIORG) has a current Inventories, Work In Process of ₹0.00 Mil. The current Inventories, Work In Process is ₹0.00 Mil. Medicamen Organics' overall GF Score™ is 32/100 with 11 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Inventories, Work In Process calculated?
Inventories, Work In Process is calculated from a company's financial statements. For Medicamen Organics (NSE:MEDIORG), the current Inventories, Work In Process is ₹0.00 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Medicamen Organics Business Description

Address Ashok Vihar Phase II, 10, Community Center No. 2, New Delhi, IND, 110052
Medicamen Organics Ltd develops, manufactures, and distributes a wide range of pharmaceutical dosage forms, including Tablets, Capsules, Oral Liquids, Ointments, Gel, Syrups, Suspension and Dry powders. The company operates two WHO Good Manufacturing Practice certified facilities in India, producing products for both domestic and international clients. It provides contract manufacturing and loan license services to various pharmaceutical companies and exports to several countries across Africa, CIS, and South Asia. The principal source of revenue is through the manufacturing, export, and contract services focused on generic and branded pharmaceutical formulations.
32GF Score

Get the complete analysis for NSE:MEDIORG

Inventories, Work In Process is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹23.80
Price